Jiangsu Bioperfectus Technologies Co., Ltd.
688399
Rank in Stocks
#12951
Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research,... Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
Share Price
$3.44
Last synced: 2026-11-10
Market Cap
$427.30M
Change (1 day)
1.10%
Change (1 year)
-52.60%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Jiangsu Bioperfectus Technologies Co., Ltd. (688399)
Category
Healthcare
Operating Margin for Jiangsu Bioperfectus Technologies Co., Ltd. (688399)
Operating Margin as of November 2026 TTM: -24.40%
According to Jiangsu Bioperfectus Technologies Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -24.40%. At the end of 2025 the company had an operating margin of -26.66%.
Operating Margin history for Jiangsu Bioperfectus Technologies Co., Ltd. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -24.40% | -8.48% |
| 2025 | -26.66% | -1,157.94% |
| 2024 | 2.52% | -102.78% |
| 2023 | -90.54% | -333.11% |
| 2022 | 38.84% | -20.94% |
| 2021 | 49.13% | -11.25% |
| 2020 | 55.36% | 68.22% |
| 2019 | 32.91% | 3.59% |
| 2018 | 31.77% | 17.67% |
| 2017 | 27.00% | 317.31% |
| 2016 | 6.47% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -101.58% |
US
|
|
| -149.01% | -93.89% |
US
|
|
| 25.57% | -101.05% |
AU
|
|
| 31.23% | -101.28% |
BE
|
|
| 29.35% | -101.20% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin
What is Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin?
Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin is -24.40%, as of Nov 2026.
What was Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin in 2025?
In 2025, Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin was -26.66%, compared with 2.52% in 2024.
How has Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin was highest in 2020 (55.36%) and lowest in 2023 (-90.54%).
How does Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin compare with similar companies?
Jiangsu Bioperfectus Technologies Co., Ltd.'s operating margin (-24.40%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.